and CDK7/9 with the inhibitor BTX-A51 in human liposarcomas,” highlights new mechanistic and efficacy data in patient-derived cell lines and xenograft models. One of the most significant ...

Portage Biotech announced confirmatory preclinical efficacy data for PORT-7, demonstrating superior single agent activity compared to anti-PD1 antibody, which is a significant advancement in ...

SELLAS Life Sciences Group, Inc. announced plans to present preclinical data on the efficacy of its cancer therapy SLS009 (tambiciclib) at the upcoming ASCO Annual Meeting, scheduled for May 30 to ...

The data were presented at the American Association ... along with its limited efficacy in tumors with lower Nectin-4 expression, underscores the need for a differentiated Nectin-4 ADC with ...

Compelling Phase 1 safety and efficacy data for FAP-Dox (AVA6000) with preliminary evidence of efficacy in salivary gland ...